Physician profile
Michael R Lee
NPI 1265635866
$2,813.28
in general payments reported to CMS, 2019-2025
12 companies · $824 in 2025
The $824 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $107 · 2021: $20.24 · 2022: $492 · 2023: $236 · 2024: $386 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $833.35 | 2022-2025 | Phasix Mesh |
| Allergan, INC. | $536.25 | 2019-2022 | |
| Kerecis Limited | $325.03 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $317.43 | 2023-2025 | |
| Sientra, INC. | $201.42 | 2019 | |
| Biocircuit Technologies INC | $154.79 | 2025 | Nerve Tape |
| Avita Medical Americas, LLC | $148.55 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $124.25 | 2019 | |
| Mentor Worldwide LLC | $114.99 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $21.98 | 2019 | |
| Clozex Medical INC | $20.24 | 2021 | |
| Theragen, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.